Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kbl Merger Corp IV (KBLM)

Kbl Merger Corp IV (KBLM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,807
  • Shares Outstanding, K 5,372
  • Annual Sales, $ 0 K
  • Annual Income, $ -90 K
  • 60-Month Beta 0.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.35
Trade KBLM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 07/02/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.60 +8.48%
on 11/06/20
11.35 -56.05%
on 10/23/20
-5.92 (-54.26%)
since 10/06/20
3-Month
4.60 +8.48%
on 11/06/20
11.47 -56.48%
on 09/08/20
-5.99 (-54.55%)
since 08/05/20
52-Week
4.60 +8.48%
on 11/06/20
11.50 -56.61%
on 06/17/20
-5.56 (-52.70%)
since 11/06/19

Most Recent Stories

More News
KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC), today announced the successful completion of its acquisition...

KBLM : 4.99 (-17.52%)
KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180...

KBLM : 4.99 (-17.52%)
SPAC Merger Fires Boosters for 180 Life Sciences’ Exploration in Unmet Medical Needs of Anti-inflammatories Space

Clinical stage biotechnology company  180 Life Sciences Corp. , whose scientific teams are led by drug developers renowned for producing some of the largest-selling pharmaceuticals to ever come to market,...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
KBLMW : 0.1720 (-3.37%)
BioMedNewsBreaks – KBL Merger Corp. IV’s (NASDAQ: KBLM) Special Meeting to be Held November 5, 2020, 180 Life Sciences Featured in Exclusive Broadcast

KBL Merger Corp. (NASDAQ, KBLMKBL, KBLMR, KBLMW) (“KBL”), a special purpose acquisition company (“SPAC”) that previously announced the agreement to acquire  180 Life Sciences Corp. , today announced...

KBLM : 4.99 (-17.52%)
Innovative Companies with Blockbuster Potential Catch SPAC Attention

NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp....

KBLMW : 0.1720 (-3.37%)
KBLMR : 0.3920 (+3.19%)
KBLM : 4.99 (-17.52%)
KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020

NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180...

KBLM : 4.99 (-17.52%)
In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster

NetworkNewsWire Editorial Coverage : Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery...

KBLMR : 0.3920 (+3.19%)
KBLMW : 0.1720 (-3.37%)
KBLM : 4.99 (-17.52%)
ALXN : 182.50 (+1.70%)
GILD : 67.75 (-0.47%)
LLY : 750.77 (-0.12%)
VRTX : 397.36 (+0.20%)
UPDATE -- The Quest for Blockbuster Drugs Continues

NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger...

KBLMW : 0.1720 (-3.37%)
KBLMR : 0.3920 (+3.19%)
KBLM : 4.99 (-17.52%)
NetworkNewsBreaks – KBL Merger Corp. IV (NASDAQ: KBLM) Featured in Seeking Alpha Article Discussing ‘Blockbuster Year for SPACs’

KBL Merger Corp. (NASDAQ: KBLM), a special purpose acquisition company (“SPAC”) that previously announced the acquisition of 180 Life Sciences , was featured in a Seeking Alpha news article. The...

KBLM : 4.99 (-17.52%)
IMTX : 10.40 (-1.98%)
IMVT : 30.47 (+3.82%)
AHCO : 9.88 (+0.41%)
CCXXU : N/A (N/A)
DKNG : 43.72 (-1.13%)
FEAC : 17.68 (-1.78%)
180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents

KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition corporation (“SPAC”) that has signed a detailed merger agreement with  180 Life Sciences Corp. , announced that the company has continued...

KBLM : 4.99 (-17.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

KBL Merger Corp. IV is a blank check company. It provides capital stock exchange, asset acquisition, stock purchase, investment management and other financial services. KBL Merger Corp. IV is based in Newark, United States.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 6.66
1st Resistance Point 5.82
Last Price 4.99
1st Support Level 4.38
2nd Support Level 3.77
3rd Support Level N/A

See More

52-Week High 11.50
Fibonacci 61.8% 8.86
Fibonacci 50% 8.05
Fibonacci 38.2% 7.24
Last Price 4.99
52-Week Low 4.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar